» Articles » PMID: 17668242

Transplantation of Renal Primordia: Renal Organogenesis

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2007 Aug 2
PMID 17668242
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Dialysis and allotransplantation of human kidneys represent effective therapies to replace kidney function, but the former replaces only a small component of renal function, and the latter is limited by lack of organ availability. Xenotransplantation of whole kidneys from nonprimate donors is complicated by humoral and severe cellular rejection. The use of individual cells or groups of cells to repair damaged tissue (cellular therapies) offers an alternative for renal tissue replacement. However, recapitulation of complex functions such glomerular filtration and reabsorption and secretion of solutes that are dependent on a three-dimensionally integrated kidney structure are beyond the scope of most cellular replacement therapies. The use of nonvascularized embryonic renal primordia for transplantation circumvents humoral rejection of xenogeneic tissue and ameliorates cellular rejection. Renal primordia are preprogrammed to attract a vasculature and differentiate into a kidney and in this manner undergo organogenesis after transplantation into the mesentery of hosts. Here we review a decade's progress in renal organogenesis.

Citing Articles

Sildenafil Citrate Enhances Renal Organogenesis Following Metanephroi Allotransplantation into Non-Immunosuppressed Hosts.

Garcia-Dominguez X, Vera-Donoso C, Lopez-Moncholi E, Moreno-Manzano V, Vicente J, Marco-Jimenez F J Clin Med. 2022; 11(11).

PMID: 35683456 PMC: 9181797. DOI: 10.3390/jcm11113068.


Current Bioengineering and Regenerative Strategies for the Generation of Kidney Grafts on Demand.

Garcia-Dominguez X, Vicente J, Vera-Donoso C, Marco-Jimenez F Curr Urol Rep. 2017; 18(1):2.

PMID: 28092070 DOI: 10.1007/s11934-017-0650-6.


Current strategies and challenges in engineering a bioartificial kidney.

Kim S, Fissell W, Humes D, Roy S Front Biosci (Elite Ed). 2015; 7(2):215-28.

PMID: 25553375 PMC: 4383659. DOI: 10.2741/E729.


Classic and current opinion in embryonic organ transplantation.

Hammerman M Curr Opin Organ Transplant. 2014; 19(2):133-9.

PMID: 24535425 PMC: 4094307. DOI: 10.1097/MOT.0000000000000054.


Engineering kidneys from simple cell suspensions: an exercise in self-organization.

Davies J, Chang C Pediatr Nephrol. 2013; 29(4):519-24.

PMID: 23989397 PMC: 3928531. DOI: 10.1007/s00467-013-2579-4.


References
1.
Foglia R, DiPreta J, Statter M, Donahoe P . Fetal allograft survival in immunocompetent recipients is age dependent and organ specific. Ann Surg. 1986; 204(4):402-10. PMC: 1251308. DOI: 10.1097/00000658-198610000-00008. View

2.
Rogers S, Liapis H, Hammerman M . Transplantation of metanephroi across the major histocompatibility complex in rats. Am J Physiol Regul Integr Comp Physiol. 2000; 280(1):R132-6. DOI: 10.1152/ajpregu.2001.280.1.R132. View

3.
Hammerman M . Regulation of cell survival during renal development. Pediatr Nephrol. 1998; 12(7):596-602. DOI: 10.1007/s004670050513. View

4.
Velasco A, Hegre O . Decreased immunogenicity of fetal kidneys: the role of passenger leukocytes. J Pediatr Surg. 1989; 24(1):59-63; discussion 63. DOI: 10.1016/s0022-3468(89)80303-3. View

5.
Dekel B, Marcus H, Herzel B, Bocher W, Passwell J, Reisner Y . In vivo modulation of the allogeneic immune response by human fetal kidneys: the role of cytokines, chemokines, and cytolytic effector molecules. Transplantation. 2000; 69(7):1470-8. DOI: 10.1097/00007890-200004150-00044. View